Free Trial
→ Nobody Understands Why Trump Is Invading Iran (here’s the answer) (From Banyan Hill Publishing) (Ad)tc pixel Free SVFCX Stock Alerts

Smead Value C (SVFCX) Financials

Smead Value C logo
$87.58 -1.64 (-1.84%)
As of 05/7/2026
Compare
Annual Income Statements for Smead Value C

Annual Income Statements for Smead Value C

This table shows Smead Value C's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2020 2021 2022 2023 2024 2025
Period end date 9/26/2020 9/25/2021 9/24/2022 9/30/2023 9/28/2024 9/27/2025
Net Income / (Loss) Attributable to Common Shareholders		 -110 0.00 -6.86 -24 -13 -17
Consolidated Net Income / (Loss)		 -110 -122 -139 -208 -85 -91
Net Income / (Loss) Continuing Operations		 -110 -122 -139 -208 -85 -91
Total Pre-Tax Income 		-110 -122 -139 -213 -80 -79
Total Operating Income		 -110 -122 -140 -223 -117 -115
Total Gross Profit		 -19 10 100 190 246 423
Total Revenue		 92 252 593 1,177 1,788 2,247
Operating Revenue		 92 252 593 1,177 1,788 2,247
Total Cost of Revenue		 111 241 494 987 1,543 1,824
Operating Cost of Revenue		 111 241 494 987 1,543 1,824
Total Operating Expenses		 91 133 240 413 362 538
Selling, General & Admin Expense		 36 59 116 218 189 299
Research & Development Expense		 56 73 124 195 173 216
Restructuring Charge		 - - - 0.00 0.00 23
Total Other Income / (Expense), net		 0.81 0.07 1.29 11 37 36
Other Income / (Expense), net		 0.81 0.07 1.29 11 37 36
Income Tax Expense		 -0.05 0.00 0.00 -4.62 4.21 -1.63
Other Gains / (Losses), net		 - - 0.00 0.00 -0.78 -14
Net Income / (Loss) Attributable to Noncontrolling Interest		 0.00 0.00 -60 -184 -71 -74
Basic Earnings per Share		 $0.00 $0.00 ($0.13) ($0.37) ($0.14) ($0.16)
Weighted Average Basic Shares Outstanding		 0.00 0.00 54.09M 64.34M 95.70M 108.67M
Diluted Earnings per Share		 $0.00 $0.00 ($0.13) ($0.37) ($0.14) ($0.16)
Weighted Average Diluted Shares Outstanding		 0.00 0.00 54.09M 64.34M 95.70M 108.67M
Weighted Average Basic & Diluted Shares Outstanding		 - 0.00 553.91M 557.24M 587.42M 591.52M

Quarterly Income Statements for Smead Value C

This table shows Smead Value C's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 9/30/2023 12/30/2023 3/30/2024 6/29/2024 9/28/2024 12/28/2024 3/29/2025 6/28/2025 9/27/2025 12/27/2025 3/28/2026
Net Income / (Loss) Attributable to Common Shareholders		 -6.21 -2.84 -8.81 -4.68 2.84 -3.18 -1.80 -5.91 -3.62 2.60 1.97
Consolidated Net Income / (Loss)		 -45 -19 -55 -27 16 -17 -9.85 -32 -19 13 9.43
Net Income / (Loss) Continuing Operations		 -45 -19 -55 -27 16 -17 -9.85 -32 -19 13 9.43
Total Pre-Tax Income 		-50 -19 -55 -26 20 -15 -8.76 -28 -14 20 17
Total Operating Income		 -54 -25 -65 -38 11 -23 -20 -37 -22 6.53 6.09
Total Gross Profit		 59 64 30 55 96 81 111 108 127 133 150
Total Revenue		 392 360 393 470 565 487 550 592 618 630 676
Operating Revenue		 392 360 393 470 565 487 550 592 618 630 676
Total Cost of Revenue		 333 296 363 415 468 406 439 484 491 497 527
Operating Cost of Revenue		 333 296 363 415 468 406 439 484 491 497 527
Total Operating Expenses		 113 89 95 93 86 104 131 144 149 127 144
Selling, General & Admin Expense		 67 47 49 48 45 61 73 76 84 81 93
Research & Development Expense		 46 42 46 45 40 43 58 52 59 43 51
Restructuring Charge		 - - - 0.00 - 0.00 0.00 16 - 2.67 0.01
Total Other Income / (Expense), net		 3.66 6.20 9.81 12 9.42 7.82 12 8.45 8.08 13 11
Other Income / (Expense), net		 3.66 6.20 9.81 12 9.42 7.82 12 8.45 8.08 13 11
Income Tax Expense		 -4.86 0.17 -0.25 0.18 4.11 0.15 -1.40 0.04 -0.42 0.62 0.57
Other Gains / (Losses), net		 - 0.00 0.00 -0.54 - -1.56 -2.49 -3.78 -5.89 -5.80 -6.95
Net Income / (Loss) Attributable to Noncontrolling Interest		 -39 -16 -46 -22 13 -14 -8.05 -26 -16 11 7.46
Basic Earnings per Share		 ($0.08) ($0.03) ($0.09) ($0.05) $0.03 ($0.03) ($0.02) ($0.05) ($0.04) $0.02 $0.02
Weighted Average Basic Shares Outstanding		 64.34M 83.32M 93.04M 102.41M 95.70M 106.10M 107.73M 109.20M 108.67M 115.47M 125.54M
Diluted Earnings per Share		 ($0.08) ($0.03) ($0.09) ($0.05) $0.03 ($0.03) ($0.02) ($0.05) ($0.04) $0.02 $0.01
Weighted Average Diluted Shares Outstanding		 64.34M 83.32M 93.04M 102.41M 95.70M 106.10M 107.73M 109.20M 108.67M 127.87M 134.36M
Weighted Average Basic & Diluted Shares Outstanding		 557.24M 577.06M 584.63M 585.58M 587.42M 588.39M 589.61M 590.49M 591.52M 602.17M 602.71M

Annual Cash Flow Statements for Smead Value C

This table details how cash moves in and out of Smead Value C's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2020 2021 2022 2023 2024 2025
Period end date 9/26/2020 9/25/2021 9/24/2022 9/30/2023 9/28/2024 9/27/2025
Net Change in Cash & Equivalents		 -30 98 197 -93 469 517
Net Cash From Operating Activities		 -124 110 -148 231 -58 867
Net Cash From Continuing Operating Activities		 -124 110 -148 231 -58 867
Net Income / (Loss) Continuing Operations		 -110 -122 -139 -208 -85 -91
Consolidated Net Income / (Loss)		 -110 -122 -139 -208 -85 -91
Depreciation Expense		 5.73 4.49 5.99 9.48 21 40
Amortization Expense		 - - - 1.84 2.63 4.53
Non-Cash Adjustments To Reconcile Net Income		 0.11 0.15 32 179 137 159
Changes in Operating Assets and Liabilities, net		 -21 227 -47 248 -133 755
Net Cash From Investing Activities		 -5.06 -12 -18 -299 156 -351
Net Cash From Continuing Investing Activities		 -5.07 -12 -18 -299 156 -351
Purchase of Property, Plant & Equipment		 -5.07 -12 -18 -21 -44 -79
Acquisitions		 - - 0.00 0.00 -90 -272
Purchase of Investments		 - 0.00 0.00 -408 -49 0.00
Sale of Property, Plant & Equipment		 - 0.00 0.00 0.07 0.00 0.00
Sale and/or Maturity of Investments		 - 0.00 0.00 130 340 0.00
Net Cash From Financing Activities		 100 0.00 362 -24 371 0.67
Net Cash From Continuing Financing Activities		 100 0.00 362 -24 371 0.67
Payment of Dividends		 0.00 0.00 -300 0.00 -48 -1.18
Issuance of Common Equity		 0.00 0.00 0.00 2.57 264 4.86
Other Financing Activities, net		 0.00 0.00 662 -27 156 -3.01
Effect of Exchange Rate Changes		 -0.68 0.97 0.57 0.23 - -0.03

Quarterly Cash Flow Statements for Smead Value C

This table details how cash moves in and out of Smead Value C's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 9/30/2023 12/30/2023 3/30/2024 6/29/2024 9/28/2024 12/28/2024 3/29/2025 6/28/2025 9/27/2025 12/27/2025 3/28/2026
Net Change in Cash & Equivalents		 3.29 227 416 -31 -143 176 52 -177 467 574 190
Net Cash From Operating Activities		 45 -30 21 50 -99 205 270 -138 531 192 261
Net Cash From Continuing Operating Activities		 45 -30 21 50 -99 205 270 -138 531 192 261
Net Income / (Loss) Continuing Operations		 -45 -19 -55 -47 16 -17 -21 -32 -19 13 9.43
Consolidated Net Income / (Loss)		 -45 -19 -55 -47 16 -17 -21 -32 -19 13 9.43
Depreciation Expense		 4.71 3.20 3.16 11 6.43 6.86 12 14 5.48 8.70 11
Amortization Expense		 - - - - - 0.79 - - - 1.39 2.54
Non-Cash Adjustments To Reconcile Net Income		 51 30 53 28 25 27 43 57 31 55 60
Changes in Operating Assets and Liabilities, net		 34 -44 19 59 -147 187 235 -178 509 113 178
Net Cash From Investing Activities		 -28 99 137 -34 -45 -25 -221 -39 -66 -41 -75
Net Cash From Continuing Investing Activities		 -28 99 137 -34 -45 -25 -221 -39 -66 -41 -75
Purchase of Property, Plant & Equipment		 -0.96 -2.99 -2.87 -17 -21 -7.36 -21 -15 -36 -2.05 -43
Acquisitions		 - 0.00 - - -24 -18 -200 -24 -29 -39 -31
Net Cash From Financing Activities		 -13 159 258 -48 1.75 -3.86 2.85 0.06 1.62 423 3.84
Net Cash From Continuing Financing Activities		 -13 159 258 -48 1.75 -3.86 2.85 0.06 1.62 423 3.84
Issuance of Common Equity		 1.59 - - - 2.31 0.00 - - 1.62 424 3.84
Effect of Exchange Rate Changes		 0.14 -0.00 -0.01 -0.01 0.02 -0.08 0.05 0.02 -0.02 0.01 -0.02

Annual Balance Sheets for Smead Value C

This table presents Smead Value C's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2020 2021 2022 2023 2024 2025
Period end date 12/31/2020 9/25/2021 9/24/2022 9/30/2023 9/28/2024 9/27/2025
Total Assets		 0.13 281 631 1,051 1,579 2,396
Total Current Assets		 0.01 260 605 992 1,356 1,885
Cash & Equivalents		 0.00 157 353 259 727 1,245
Accounts Receivable		 - 63 105 190 420 368
Inventories, net		 - 34 92 136 106 164
Prepaid Expenses		 0.01 6.37 26 85 101 87
Other Current Assets		 - 0.49 29 35 1.06 21
Plant, Property, & Equipment, net		 0.00 19 25 35 97 118
Total Noncurrent Assets		 0.13 1.50 0.99 24 126 393
Long-Term Investments		 - - - 0.00 81 123
Goodwill		 - - - - 0.00 60
Intangible Assets		 - 1.16 0.65 0.22 3.66 79
Other Noncurrent Operating Assets		 0.13 0.33 0.34 24 41 131
Total Liabilities & Shareholders' Equity		 0.13 281 631 1,051 1,579 2,396
Total Liabilities		 0.13 558 562 1,053 1,188 1,918
Total Current Liabilities		 0.13 337 523 1,025 1,017 1,729
Accounts Payable		 0.01 28 68 110 175 287
Accrued Expenses		 0.10 31 47 128 166 200
Current Deferred Revenue		 - 259 394 787 676 1,242
Total Noncurrent Liabilities		 0.00 221 39 28 171 189
Noncurrent Deferred Revenue		 - 217 31 0.00 129 125
Other Noncurrent Operating Liabilities		 0.00 3.99 7.90 28 42 64
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 0.01 -1,113 69 -2.72 390 478
Total Preferred & Common Equity		 0.01 0.00 7.18 0.08 197 220
Total Common Equity		 0.01 -1,113 7.18 0.08 197 220
Common Stock		 0.03 17 1,238 1,254 1,524 1,557
Retained Earnings		 -0.02 -1,155 -1,287 -1,310 -1,324 -1,334
Accumulated Other Comprehensive Income / (Loss)		 - -2.09 -2.29 -1.69 -2.59 -2.70
Noncontrolling Interest		 - 0.00 62 -2.80 193 258

Quarterly Balance Sheets for Smead Value C

This table presents Smead Value C's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026
Period end date 12/24/2022 3/25/2023 6/24/2023 12/30/2023 3/30/2024 6/29/2024 12/28/2024 3/29/2025 6/28/2025 12/27/2025 3/28/2026
Total Assets		 809 910 970 1,316 1,553 1,500 1,716 1,964 1,827 2,994 3,495
Total Current Assets		 772 866 922 1,251 1,449 1,313 1,458 1,498 1,426 2,458 2,922
Cash & Equivalents		 351 257 255 486 901 870 903 955 778 1,819 2,009
Accounts Receivable		 146 188 165 293 267 203 358 298 373 357 586
Inventories, net		 111 140 167 138 120 132 109 146 139 184 201
Prepaid Expenses		 32 39 36 104 110 101 86 94 102 70 82
Other Current Assets		 35 37 42 42 1.17 6.75 3.22 4.98 36 28 44
Plant, Property, & Equipment, net		 30 36 41 35 75 81 105 124 73 116 146
Total Noncurrent Assets		 6.60 7.59 7.17 30 29 106 152 342 328 420 427
Long-Term Investments		 - - - - - - 86 85 106 144 136
Goodwill		 - - - - - - - 69 61 60 60
Intangible Assets		 0.54 0.43 0.34 0.00 0.00 0.00 15 126 83 75 87
Other Noncurrent Operating Assets		 6.06 7.16 6.83 30 29 106 51 63 79 141 144
Total Liabilities & Shareholders' Equity		 809 910 970 1,316 1,553 1,500 1,716 1,964 1,827 2,994 3,495
Total Liabilities		 759 888 948 1,150 1,159 1,154 1,322 1,543 1,384 2,034 2,468
Total Current Liabilities		 736 850 898 1,096 1,076 1,023 1,197 1,473 1,317 1,784 2,022
Accounts Payable		 61 88 74 103 133 128 206 220 216 266 294
Accrued Expenses		 73 71 61 116 119 177 203 166 184 207 251
Current Deferred Revenue		 580 665 742 840 815 718 787 1,086 918 1,311 1,476
Total Noncurrent Liabilities		 23 38 50 54 83 131 125 70 67 250 446
Noncurrent Deferred Revenue		 9.34 24 33 17 45 82 77 8.15 5.04 189 384
Other Noncurrent Operating Liabilities		 13 15 17 37 39 49 48 62 62 61 62
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 50 21 22 166 394 347 394 422 443 960 1,028
Total Preferred & Common Equity		 5.32 2.37 2.48 -57 197 197 197 205 211 664 686
Total Common Equity		 5.32 2.37 2.48 -57 197 197 197 205 211 664 686
Common Stock		 1,243 1,246 1,250 1,258 1,522 1,526 1,527 1,539 1,551 1,998 2,018
Retained Earnings		 -1,294 -1,300 -1,304 -1,313 -1,322 -1,327 -1,327 -1,331 -1,337 -1,331 -1,329
Accumulated Other Comprehensive Income / (Loss)		 -2.31 -2.09 -1.83 -1.77 -2.37 -2.63 -2.70 -2.70 -2.68 -2.69 -2.71
Noncontrolling Interest		 45 19 19 223 197 150 197 216 233 296 342

Annual Metrics And Ratios for Smead Value C

This table displays calculated financial ratios and metrics derived from Smead Value C's official financial filings.

Metric 2020 2021 2022 2023 2024 2025
Period end date 9/26/2020 9/25/2021 9/24/2022 9/30/2023 9/28/2024 9/27/2025
Growth Metrics		 - - - - - -
Revenue Growth		 0.00% 173.56% 135.52% 98.36% 51.94% 25.65%
EBITDA Growth		 0.00% -13.47% -12.97% -51.17% 72.07% 38.06%
EBIT Growth		 0.00% -11.63% -13.71% -52.79% 62.50% 0.93%
NOPAT Growth		 0.00% -10.88% -14.70% -59.02% 47.71% 1.47%
Net Income Growth		 0.00% -11.68% -13.71% -49.47% 59.27% -7.51%
EPS Growth		 0.00% 0.00% 0.00% -184.62% 62.16% -14.29%
Operating Cash Flow Growth		 0.00% 188.14% -235.30% 255.68% -125.16% 1,592.74%
Free Cash Flow Firm Growth		 0.00% 0.00% -171.09% 143.44% -296.81% 282.46%
Invested Capital Growth		 0.00% -1,814,030.72% 34.38% -92.69% 23.67% -111.44%
Revenue Q/Q Growth		 0.00% 0.00% 26.42% 14.33% 8.05% 2.46%
EBITDA Q/Q Growth		 0.00% 0.00% 17.77% 2.85% 48.21% -692.31%
EBIT Q/Q Growth		 0.00% 0.00% 16.88% 1.38% 38.83% -75.62%
NOPAT Q/Q Growth		 0.00% 0.00% 16.26% 0.17% 27.75% -39.65%
Net Income Q/Q Growth		 0.00% 0.00% 17.53% 3.04% 32.83% -62.76%
EPS Q/Q Growth		 0.00% 0.00% -218.18% 5.13% 36.36% -77.78%
Operating Cash Flow Q/Q Growth		 0.00% 0.00% -78.21% 71.28% -167.66% 265.99%
Free Cash Flow Firm Q/Q Growth		 0.00% 0.00% 0.00% 1,957.58% -168.75% 372.46%
Invested Capital Q/Q Growth		 0.00% 0.00% 15.96% -12.05% 20.09% -101.22%
Profitability Metrics		 - - - - - -
Gross Margin		 -20.56% 4.15% 16.80% 16.12% 13.74% 18.81%
EBITDA Margin		 -112.76% -46.77% -22.43% -17.10% -3.14% -1.55%
Operating Margin		 -119.86% -48.58% -23.66% -18.97% -6.53% -5.12%
EBIT Margin		 -118.98% -48.55% -23.44% -18.06% -4.46% -3.51%
Profit (Net Income) Margin		 -118.93% -48.55% -23.44% -17.66% -4.74% -4.05%
Tax Burden Percent		 99.96% 100.00% 100.00% 97.83% 106.26% 115.31%
Interest Burden Percent		 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 -323,225.82% 0.00% 0.00% 0.00% 0.00% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)		 -504,955.96% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Net Nonoperating Assets (RNNOA)		 -1,456,445.94% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Equity (ROE)		 -1,779,671.76% 88.33% 133.72% -627.85% -43.71% -20.85%
Cash Return on Invested Capital (CROIC)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Return on Assets (OROA)		 -82,441.46% -87.16% -30.51% -25.27% -6.06% -3.97%
Return on Assets (ROA)		 -82,406.10% -87.16% -30.51% -24.72% -6.44% -4.57%
Return on Common Equity (ROCE)		 -1,779,671.76% 355.02% 710.97% -68.89% -22.26% -9.99%
Return on Equity Simple (ROE_SIMPLE)		 0.00% 0.00% -1,936.09% 0.00% -42.93% 0.00%
Net Operating Profit after Tax (NOPAT)		 -77 -86 -98 -156 -82 -81
NOPAT Margin		 -83.90% -34.01% -16.56% -13.28% -4.57% -3.58%
Net Nonoperating Expense Percent (NNEP)		 181,730.14% -46.80% -16.01% -11.49% -0.44% -0.97%
Return On Investment Capital (ROIC_SIMPLE)		 - - - - - -16.66%
Cost of Revenue to Revenue		 120.56% 95.85% 83.21% 83.88% 86.26% 81.19%
SG&A Expenses to Revenue		 38.64% 23.60% 19.53% 18.52% 10.57% 13.30%
R&D to Revenue		 60.66% 29.13% 20.92% 16.57% 9.70% 9.61%
Operating Expenses to Revenue		 99.31% 52.73% 40.45% 35.09% 20.27% 23.93%
Earnings before Interest and Taxes (EBIT)		 -110 -122 -139 -213 -80 -79
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -104 -118 -133 -201 -56 -35
Valuation Ratios		 - - - - - -
Price to Book Value (P/BV)		 45,498.86 0.00 809.95 226,609.56 75.77 139.11
Price to Tangible Book Value (P/TBV)		 45,498.86 0.00 890.52 0.00 77.20 374.11
Price to Revenue (P/Rev)		 3.04 1.60 9.81 15.79 8.36 13.70
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 11,714.26 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Revenue (EV/Rev)		 3.04 4.29 9.32 15.32 8.01 13.21
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 9.87 0.00 78.14 0.00 34.24
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 3.11 0.00 167.84 0.00 76.93
Leverage & Solvency		 - - - - - -
Debt to Equity		 2.88 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage		 2.88 0.57 2.45 -13.57 -3.50 -2.49
Leverage Ratio		 21.60 -1.01 -4.38 25.40 6.79 4.56
Compound Leverage Factor		 21.60 -1.01 -4.38 25.40 6.79 4.56
Debt to Total Capital		 74.26% 0.00% 0.00% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital		 74.26% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% -301.93% 89.58% 103.02% 49.44% 54.20%
Common Equity to Total Capital		 25.74% 401.93% 10.42% -3.02% 50.56% 45.80%
Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score		 -703.54 -6.20 3.72 9.25 7.59 9.76
Noncontrolling Interest Sharing Ratio		 0.00% -301.94% -431.68% 89.03% 49.07% 52.07%
Liquidity Ratios		 - - - - - -
Current Ratio		 0.05 0.77 1.16 0.97 1.33 1.09
Quick Ratio		 0.00 0.65 0.88 0.72 1.13 0.93
Cash Flow Metrics		 - - - - - -
Free Cash Flow to Firm (FCFF)		 0.00 348 -247 107 -211 386
Operating Cash Flow to CapEx		 -2,451.33% 900.45% -825.89% 1,085.83% -130.88% 1,096.97%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - - -
Asset Turnover		 692.88 1.80 1.30 1.40 1.36 1.13
Accounts Receivable Turnover		 0.00 0.00 7.04 7.96 5.86 5.70
Inventory Turnover		 0.00 0.00 7.87 8.66 12.73 13.49
Fixed Asset Turnover		 0.00 0.00 27.28 39.64 27.17 20.93
Accounts Payable Turnover		 12,335.11 17.23 10.24 11.07 10.82 7.90
Days Sales Outstanding (DSO)		 0.00 0.00 51.86 45.84 62.27 64.01
Days Inventory Outstanding (DIO)		 0.00 0.00 46.38 42.16 28.66 27.06
Days Payable Outstanding (DPO)		 0.03 21.18 35.66 32.98 33.73 46.20
Cash Conversion Cycle (CCC)		 -0.03 -21.18 62.58 55.02 57.20 44.87
Capital & Investment Metrics		 - - - - - -
Invested Capital		 0.02 -434 -285 -548 -418 -885
Invested Capital Turnover		 3,852.33 -1.16 -1.65 -2.83 -3.70 -3.45
Increase / (Decrease) in Invested Capital		 0.00 -434 149 -264 130 -466
Enterprise Value (EV)		 280 1,082 5,527 18,034 14,328 29,682
Market Capitalization		 280 402 5,819 18,582 14,944 30,788
Book Value per Share		 $0.00 ($27.13) $0.01 $0.00 $0.34 $0.37
Tangible Book Value per Share		 $0.00 ($27.15) $0.01 $0.00 $0.33 $0.14
Total Capital		 0.02 -277 69 -2.72 390 483
Total Debt		 0.02 0.00 0.00 0.00 0.00 0.00
Total Long-Term Debt		 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt		 0.02 -157 -353 -546 -809 -1,368
Capital Expenditures (CapEx)		 5.07 12 18 21 44 79
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 -0.10 -233 -271 -579 -389 -1,084
Debt-free Net Working Capital (DFNWC)		 -0.10 -77 82 -34 338 161
Net Working Capital (NWC)		 -0.12 -77 82 -34 338 161
Net Nonoperating Expense (NNE)		 32 37 41 52 2.96 11
Net Nonoperating Obligations (NNO)		 0.02 -157 -353 -546 -809 -1,368
Total Depreciation and Amortization (D&A)		 5.73 4.49 5.99 11 23 44
Debt-free, Cash-free Net Working Capital to Revenue		 -0.11% -92.57% -45.68% -49.21% -21.75% -48.25%
Debt-free Net Working Capital to Revenue		 -0.11% -30.39% 13.90% -2.86% 18.92% 7.16%
Net Working Capital to Revenue		 -0.13% -30.39% 13.90% -2.86% 18.92% 7.16%
Earnings Adjustments		 - - - - - -
Adjusted Basic Earnings per Share		 $0.00 ($0.38) ($0.13) ($0.37) ($0.14) ($0.16)
Adjusted Weighted Average Basic Shares Outstanding		 0.00 41.40M 54.09M 64.34M 95.70M 108.67M
Adjusted Diluted Earnings per Share		 $0.00 ($0.38) ($0.13) ($0.37) ($0.14) ($0.16)
Adjusted Weighted Average Diluted Shares Outstanding		 0.00 41.40M 54.09M 64.34M 95.70M 108.67M
Adjusted Basic & Diluted Earnings per Share		 $0.00 ($0.38) $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 0.00 34.61M 553.91M 557.24M 587.42M 591.52M
Normalized Net Operating Profit after Tax (NOPAT)		 -77 -86 -98 -156 -82 -64
Normalized NOPAT Margin		 -83.90% -34.01% -16.56% -13.28% -4.57% -2.87%
Pre Tax Income Margin		 -118.98% -48.55% -23.44% -18.06% -4.46% -3.51%
Debt Service Ratios		 - - - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - - -
Dividend Payout Ratio		 0.00% 0.00% -215.69% 0.00% -56.94% -1.29%
Augmented Payout Ratio		 0.00% 0.00% -215.69% 0.00% -56.94% -1.29%

Quarterly Metrics And Ratios for Smead Value C

This table displays calculated financial ratios and metrics derived from Smead Value C's official financial filings.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 9/30/2023 12/30/2023 3/30/2024 6/29/2024 9/28/2024 12/28/2024 3/29/2025 6/28/2025 9/27/2025 12/27/2025 3/28/2026
DEI Shares Outstanding		 - - - - - - - - - - 602,171,792.00
DEI Adjusted Shares Outstanding		 - - - - - - - - - - 602,171,792.00
DEI Earnings Per Adjusted Shares Outstanding		 - - - - - - - - - - 0.00
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 60.34% 74.47% 47.40% 50.83% 44.06% 35.21% 39.74% 25.89% 9.55% 29.44% 23.07%
EBITDA Growth		 11.46% 76.08% 2.69% 58.19% 158.67% 41.66% 84.47% 9.18% -134.06% 498.19% 775.14%
EBIT Growth		 5.60% 72.10% 0.63% 33.44% 140.39% 11.08% 63.06% -8.08% -167.41% 230.55% 293.47%
NOPAT Growth		 0.69% 63.92% -12.43% 10.45% 123.00% 1.87% 50.60% 2.83% -275.42% 139.33% 141.07%
Net Income Growth		 12.57% 71.95% 1.06% 31.61% 135.13% 2.89% 60.90% -19.46% -220.03% 179.23% 195.71%
EPS Growth		 20.00% 75.00% 10.00% 28.57% 137.50% 0.00% 55.56% 0.00% -233.33% 166.67% 150.00%
Operating Cash Flow Growth		 186.43% -129.84% -32.70% -6.53% -323.19% 780.02% 1,179.30% -374.58% 633.97% -6.58% -3.05%
Free Cash Flow Firm Growth		 220.76% -85.46% -82.21% -93.35% -153.58% -27.31% -45.94% -1,457.34% 472.61% 492.80% 981.87%
Invested Capital Growth		 -92.69% -28.19% -26.46% -7.03% 23.67% -16.86% -10.93% 16.03% -111.44% -68.46% -80.61%
Revenue Q/Q Growth		 25.67% -8.15% 9.28% 10.85% 20.03% -13.79% 12.94% 7.73% 4.45% 1.86% 7.38%
EBITDA Q/Q Growth		 -24.46% 65.54% -230.68% 59.70% 274.64% -134.26% 11.95% -72.37% 40.96% 463.80% 3.15%
EBIT Q/Q Growth		 -28.67% 62.41% -191.44% 36.79% 178.08% -182.77% -21.06% -38.14% 51.30% 244.46% -14.29%
NOPAT Q/Q Growth		 -28.39% 53.46% -158.55% 26.17% 132.98% -298.53% -30.17% -14.03% 40.47% 141.51% -6.92%
Net Income Q/Q Growth		 -16.22% 58.01% -187.49% 34.74% 159.70% -216.08% -15.76% -48.92% 40.02% 169.76% -29.41%
EPS Q/Q Growth		 -14.29% 62.50% -200.00% 28.57% 160.00% -200.00% -33.33% -25.00% 20.00% 150.00% -50.00%
Operating Cash Flow Q/Q Growth		 -17.39% -167.71% 169.89% 139.10% -297.25% 306.30% 31.48% -151.32% 483.60% -63.91% 36.44%
Free Cash Flow Firm Q/Q Growth		 86.23% -58.22% -24.49% -86.78% -1,600.05% 156.68% -43.84% -384.29% 511.78% -8.30% 21.99%
Invested Capital Q/Q Growth		 -12.05% 7.12% -9.53% 2.61% 20.09% -42.20% -3.97% 28.93% -101.22% -13.29% -11.48%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 15.00% 17.80% 7.68% 11.69% 17.08% 16.45% 19.62% 18.18% 20.55% 21.18% 22.17%
EBITDA Margin		 -11.63% -4.36% -13.20% -3.25% 4.74% -1.88% -1.47% -2.35% -1.33% 4.74% 4.55%
Operating Margin		 -13.76% -6.97% -16.50% -8.00% 1.93% -5.06% -5.83% -6.17% -3.52% 1.04% 0.90%
EBIT Margin		 -12.83% -5.25% -14.00% -5.53% 3.60% -3.45% -3.70% -4.75% -2.21% 3.14% 2.51%
Profit (Net Income) Margin		 -11.59% -5.30% -13.94% -5.68% 2.83% -3.81% -3.90% -5.39% -3.10% 2.12% 1.39%
Tax Burden Percent		 90.34% 100.91% 99.54% 102.76% 78.58% 110.20% 105.37% 113.59% 139.91% 67.56% 55.64%
Interest Burden Percent		 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 20.24% 0.00% 0.00% 0.00% 0.00% 3.11% 3.38%
Return on Invested Capital (ROIC)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Net Nonoperating Assets (RNNOA)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Equity (ROE)		 -627.85% -147.15% -76.32% -68.43% -43.71% -30.06% -12.45% -14.16% -20.85% -8.98% -5.73%
Cash Return on Invested Capital (CROIC)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Return on Assets (OROA)		 -17.95% -6.58% -16.57% -7.41% 4.89% -4.36% -4.36% -6.26% -2.50% 3.19% 2.31%
Return on Assets (ROA)		 -16.22% -6.64% -16.50% -7.61% 3.84% -4.81% -4.59% -7.11% -3.50% 2.15% 1.29%
Return on Common Equity (ROCE)		 -68.89% 35.28% -36.67% -36.96% -22.26% -7.49% -6.14% -7.30% -9.99% -5.71% -3.53%
Return on Equity Simple (ROE_SIMPLE)		 0.00% 278.28% -80.36% -64.14% 0.00% -42.80% -24.70% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)		 -38 -18 -45 -26 8.68 -17 -22 -26 -15 6.32 5.89
NOPAT Margin		 -9.63% -4.88% -11.55% -5.60% 1.54% -3.54% -4.08% -4.32% -2.46% 1.00% 0.87%
Net Nonoperating Expense Percent (NNEP)		 -1.70% -0.27% -1.33% -0.06% 1.07% -0.15% 0.10% -0.72% -0.36% 0.48% 0.22%
Return On Investment Capital (ROIC_SIMPLE)		 - -10.60% - - - -4.38% -5.32% -5.77% -3.15% 0.66% 0.57%
Cost of Revenue to Revenue		 85.00% 82.20% 92.32% 88.31% 82.92% 83.55% 80.38% 81.82% 79.45% 78.82% 77.83%
SG&A Expenses to Revenue		 17.08% 13.06% 12.37% 10.18% 8.04% 12.55% 14.25% 12.78% 13.52% 12.89% 13.68%
R&D to Revenue		 11.68% 11.71% 11.81% 9.51% 7.11% 8.96% 11.20% 8.81% 9.50% 6.83% 7.58%
Operating Expenses to Revenue		 28.76% 24.77% 24.18% 19.69% 15.15% 21.51% 25.45% 24.35% 24.07% 20.14% 21.27%
Earnings before Interest and Taxes (EBIT)		 -50 -19 -55 -26 20 -17 -20 -28 -14 20 17
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -46 -16 -52 -15 27 -9.16 -8.07 -14 -8.21 30 31
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 226,609.56 0.00 131.75 104.59 75.77 71.97 57.75 104.21 139.11 51.68 44.25
Price to Tangible Book Value (P/TBV)		 0.00 0.00 131.75 104.59 77.20 77.90 1,083.09 326.35 374.11 64.90 56.32
Price to Revenue (P/Rev)		 15.79 21.44 17.82 12.42 8.36 7.39 5.73 10.01 13.70 14.35 12.06
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Revenue (EV/Rev)		 15.32 21.10 17.30 11.99 8.01 6.97 5.33 9.72 13.21 13.65 11.35
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 12,798.41 957.20
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 78.14 281.95 282.17 231.09 0.00 75.40 25.93 89.97 34.24 38.24 33.79
Enterprise Value to Free Cash Flow (EV/FCFF)		 167.84 0.00 0.00 0.00 0.00 2,978.36 4,274.93 0.00 76.93 93.92 62.42
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage		 -13.57 -5.20 -3.41 -3.75 -3.50 -2.97 -2.44 -2.22 -2.49 -2.18 -2.20
Leverage Ratio		 25.40 9.83 5.93 6.70 6.79 5.42 4.31 4.21 4.56 3.48 3.77
Compound Leverage Factor		 25.40 9.83 5.93 6.70 6.79 5.42 4.31 4.21 4.56 3.48 3.77
Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 103.02% 134.46% 49.93% 43.33% 49.44% 50.11% 51.27% 52.47% 54.20% 30.87% 33.23%
Common Equity to Total Capital		 -3.02% -34.46% 50.07% 56.67% 50.56% 49.89% 48.73% 47.53% 45.80% 69.13% 66.77%
Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score		 9.76 14.59 13.36 10.73 7.80 6.60 4.70 9.72 9.85 10.59 7.89
Noncontrolling Interest Sharing Ratio		 89.03% 123.98% 51.95% 45.98% 49.07% 75.09% 50.63% 48.46% 52.07% 36.47% 38.48%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 0.97 1.14 1.35 1.28 1.33 1.22 1.02 1.08 1.09 1.38 1.45
Quick Ratio		 0.72 0.88 1.13 1.05 1.13 1.05 0.85 0.87 0.93 1.22 1.28
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 226 94 71 8.07 -121 69 39 -110 451 414 505
Operating Cash Flow to CapEx		 4,623.88% -1,007.35% 733.96% 293.90% -465.12% 2,786.83% 1,311.16% -930.54% 1,464.11% 9,334.31% 602.61%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 1.40 1.25 1.18 1.34 1.36 1.26 1.18 1.32 1.13 1.02 0.92
Accounts Receivable Turnover		 7.96 6.07 6.41 8.98 5.86 5.89 7.34 7.62 5.70 6.69 5.70
Inventory Turnover		 8.66 8.95 9.62 9.55 12.73 13.42 13.02 13.29 13.49 13.10 11.53
Fixed Asset Turnover		 39.64 40.79 26.35 27.14 27.17 27.34 20.84 28.47 20.93 21.65 18.63
Accounts Payable Turnover		 11.07 13.60 11.30 14.12 10.82 10.70 9.81 10.49 7.90 8.11 7.80
Days Sales Outstanding (DSO)		 45.84 60.17 56.94 40.64 62.27 61.97 49.73 47.92 64.01 54.59 64.05
Days Inventory Outstanding (DIO)		 42.16 40.80 37.96 38.24 28.66 27.19 28.03 27.46 27.06 27.86 31.67
Days Payable Outstanding (DPO)		 32.98 26.84 32.29 25.86 33.73 34.11 37.22 34.80 46.20 45.02 46.81
Cash Conversion Cycle (CCC)		 55.02 74.13 62.61 53.02 57.20 55.06 40.54 40.58 44.87 37.43 48.91
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 -548 -509 -558 -524 -418 -595 -619 -440 -885 -1,002 -1,117
Invested Capital Turnover		 -2.83 -2.94 -2.92 -3.27 -3.70 -3.47 -3.52 -4.55 -3.45 -2.99 -2.90
Increase / (Decrease) in Invested Capital		 -264 -112 -117 -34 130 -86 -61 84 -466 -407 -499
Enterprise Value (EV)		 18,034 28,080 25,213 19,835 14,328 13,353 11,038 21,313 29,682 32,636 28,558
Market Capitalization		 18,582 28,532 25,968 20,556 14,944 14,145 11,862 21,963 30,788 34,302 30,362
Book Value per Share		 $0.00 ($0.69) $0.34 $0.34 $0.34 $0.33 $0.35 $0.36 $0.37 $1.12 $1.14
Tangible Book Value per Share		 $0.00 ($0.69) $0.34 $0.34 $0.33 $0.31 $0.02 $0.11 $0.14 $0.89 $0.90
Total Capital		 -2.72 166 394 347 390 394 422 443 483 960 1,028
Total Debt		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Long-Term Debt		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt		 -546 -675 -951 -870 -809 -989 -1,040 -883 -1,368 -1,963 -2,145
Capital Expenditures (CapEx)		 0.96 2.99 2.87 17 21 7.36 21 15 36 2.05 43
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 -579 -520 -578 -580 -389 -641 -930 -669 -1,084 -1,145 -1,109
Debt-free Net Working Capital (DFNWC)		 -34 155 373 291 338 262 25 109 161 675 901
Net Working Capital (NWC)		 -34 155 373 291 338 262 25 109 161 675 901
Net Nonoperating Expense (NNE)		 7.66 1.50 9.40 0.39 -7.27 1.28 -1.00 6.34 3.92 -7.03 -3.54
Net Nonoperating Obligations (NNO)		 -546 -675 -951 -870 -809 -989 -1,040 -883 -1,368 -1,963 -2,145
Total Depreciation and Amortization (D&A)		 4.71 3.20 3.16 11 6.43 7.65 12 14 5.48 10 14
Debt-free, Cash-free Net Working Capital to Revenue		 -49.21% -39.07% -39.70% -35.03% -21.75% -33.50% -44.88% -30.50% -48.25% -47.89% -44.05%
Debt-free Net Working Capital to Revenue		 -2.86% 11.66% 25.59% 17.57% 18.92% 13.66% 1.23% 4.96% 7.16% 28.22% 35.79%
Net Working Capital to Revenue		 -2.86% 11.66% 25.59% 17.57% 18.92% 13.66% 1.23% 4.96% 7.16% 28.22% 35.79%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 ($0.08) $0.00 ($0.09) ($0.05) $0.03 ($0.03) ($0.04) ($0.05) ($0.04) $0.02 $0.02
Adjusted Weighted Average Basic Shares Outstanding		 64.34M 0.00 93.04M 102.41M 95.70M 106.10M 107.73M 109.20M 108.67M 115.47M 125.54M
Adjusted Diluted Earnings per Share		 ($0.08) $0.00 ($0.09) ($0.05) $0.03 ($0.03) ($0.04) ($0.05) ($0.04) $0.02 $0.01
Adjusted Weighted Average Diluted Shares Outstanding		 64.34M 0.00 93.04M 102.41M 95.70M 106.10M 107.73M 109.20M 108.67M 127.87M 134.36M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 557.24M 0.00 584.63M 585.58M 587.42M 588.39M 589.61M 590.49M 591.52M 602.17M 602.71M
Normalized Net Operating Profit after Tax (NOPAT)		 -38 -18 -45 -26 8.68 -17 -22 -14 -15 8.91 5.90
Normalized NOPAT Margin		 -9.63% -4.88% -11.55% -5.60% 1.54% -3.54% -4.08% -2.39% -2.46% 1.41% 0.87%
Pre Tax Income Margin		 -12.83% -5.25% -14.00% -5.53% 3.60% -3.45% -3.70% -4.75% -2.21% 3.14% 2.51%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% -37.80% -56.94% -58.33% -97.47% -3.10% -1.29% -2.54% -2.80%
Augmented Payout Ratio		 0.00% 0.00% 0.00% -37.80% -56.94% -58.33% -97.47% -3.10% -1.29% -2.54% -2.80%

Financials Breakdown Chart

Key Financial Trends

Below is a concise, four-year trend snapshot for Symbotic (SYM) based on quarterly cash flow, income statement, and balance sheet data. This review focuses on the last four calendar years of reported quarters (2023 through Q1 2026) and highlights the points most relevant to retail investors.

  • Revenue has trended higher over the period, rising from the mid-hundreds of millions in 2022–2023 to about $630 million in Q1 2026, signaling ongoing top-line expansion.
  • Q1 2026 net income (continuing operations) turned positive at $13.36 million, marking a meaningful quarterly improvement after years of losses.
  • Gross margin has improved and is running in the low- to mid-20% range (about 18–21% historically, with Q1 2026 around 21%), reflecting better product mix or cost control as revenue grows.
  • Cash flow from operations has been generally strong across many quarters, with Q4 2025 and Q1 2026 showing robust operating cash flow (e.g., Q4 2025 about $530.7 million; Q1 2026 about $191.5 million from continuing operations).
  • The company ended a recent period with a large cash balance (Cash & Equivalents around $1.8 billion in Q1 2026), providing substantial liquidity for growth initiatives and working-capital needs.
  • Equity financing in Q1 2026 contributed significant cash proceeds (about $424 million from issuance of common equity), boosting liquidity and financial flexibility.
  • Investing activities consistently show sizable outflows for acquisitions and property, plant & equipment, reflecting growth and capacity expansion, which can pressure near-term cash but may support long-term scale.
  • Quarter-to-quarter cash flow volatility is evident (e.g., a negative net cash from continuing operating activities in some quarters like Q3 2025), underscoring earnings-to-cash conversion variability.
  • Net income has been largely negative across many quarters outside the latest positive quarter, indicating ongoing profitability challenges on a GAAP basis.
  • Total liabilities have remained substantial and relatively elevated (ranging from roughly $1.1 billion to over $2.0 billion across periods), signaling a high leverage backdrop that investors should monitor alongside financing needs and debt service considerations.
05/09/26 05:14 AM ETAI Generated. May Contain Errors.

Smead Value C Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Smead Value C's fiscal year ends in September. Their fiscal year 2025 ended on September 27, 2025.

Smead Value C's net income appears to be on a downward trend, with a most recent value of -$91.03 million in 2025, falling from -$109.52 million in 2020. The previous period was -$84.67 million in 2024.

Smead Value C's total operating income in 2025 was -$115.01 million, based on the following breakdown:
  • Total Gross Profit: $422.61 million
  • Total Operating Expenses: $537.62 million

Over the last 5 years, Smead Value C's total revenue changed from $92.09 million in 2020 to $2.25 billion in 2025, a change of 2,340.0%.

Smead Value C's total liabilities were at $1.92 billion at the end of 2025, a 61.4% increase from 2024, and a 1,513,102.4% increase since 2020.

In the past 5 years, Smead Value C's cash and equivalents has ranged from $0.00 in 2020 to $1.24 billion in 2025, and is currently $1.24 billion as of their latest financial filing in 2025.

Over the last 5 years, Smead Value C's book value per share changed from 0.00 in 2020 to 0.37 in 2025, a change of 187,300.0%.


Related Companies

Financial statements for NASDAQ:SVFCX last updated on 5/7/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
SpaceX eyes a 1.75 trillion valuation - here's what to know
Elon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...
Brownstone Research | Sponsoredtc pixel
Iran's New Leader Just Said Something That Should Terrify Every American
Iran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...
American Alternative | Sponsoredtc pixel
Your book attached
Your Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners...
Profits Run | Sponsoredtc pixel
My feud with Zohran Mamdani
Emmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...
Stansberry Research | Sponsoredtc pixel
Sell 99% of Your Stocks, Do THIS Instead…
Millionaire Trader Exposes: "The Single Stock Income Plan" With over 6,000 stocks on the market to choose ...
The Oxford Club | Sponsoredtc pixel
Trade this between 9:30 and 10:45 am EST
The first 75 minutes of the trading day may be the most overlooked window for consistent opportunities.If you ...
Base Camp Trading | Sponsoredtc pixel
Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...
Banyan Hill Publishing | Sponsoredtc pixel
Elon Unveils AI Passive Income Stream for Millions of Americans
During Tesla's last earnings call, Elon Musk outlined a new AI-driven approach he says could generate $30,000-...
InvestorPlace | Sponsoredtc pixel